CP-Reta 60mg

Description

CP-Reta 60mg

CP-Reta is a multi-agonist peptide being investigated in multi-pathway receptor signaling models. Each vial is supplied as lyophilized powder with a 60mg label amount for in-vitro laboratory research. The batch COA documents the identity, purity and measured potency of the submitted sample. The ChoicePeps Research Library uses the CP-R3 designation.

Specifications

• Product: CP-Reta 60mg
• Label amount: 60mg per vial
• Form: Lyophilized powder
• Intended use: In-vitro laboratory research only

Batch documentation

For current batch CP-RT60-2610, Freedom Diagnostics reported 99.95% purity and 64.86mg measured content. The batch documentation is dated September 28, 2026.

These results apply to the submitted batch sample. The measured content does not change the 60mg product label amount or establish the result for every vial or future batch. View the CP-RT60-2610 COA.

Storage and handling

Before preparation, refrigerate at or below 8°C in a dry, light-protected environment, following the product label. Use a validated laboratory protocol for preparation and subsequent storage.

For educational background, read the CP-R3 research overview. For a smaller label amount, see CP-Reta 30mg and its separate batch documentation.

For in-vitro laboratory research only. Not for human or veterinary consumption. See the research-use-only information.